To Evaluate the Adhesion of TK-254RX on Healthy Participants

NCT07307794 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Esflurbiprofen Topical System

Sponsor

Teikoku Seiyaku Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]